Sensorcaine Mpf Injection, Solution
Product Images NDC 0404-9946

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sensorcaine Mpf (NDC 0404-9946). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1.jpg (Image1)

A text panel warning that 0.75% concentration of Sensorcaine injection (bupivacaine hydrochloride) is not recommended for obstetrical anesthesia due to risk of cardiac arrest and difficult resuscitation. It advises local anesthetic use only by trained clinicians, details dose-related toxicity risks including acidosis and cardiac arrest, and notes contraindications for epidural or caudal anesthesia of solutions with preservatives. It also warns against use with epinephrine or certain vasopressors and mentions pediatric use restrictions and lack of data on anesthesia mixtures.*

FDA Label Image

Image2.jpg (Image2)

A table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes alongside example drugs. Included classes are Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples include bupivacaine under Local anesthetics, and other drugs such as nitric oxide and acetaminophen.*

FDA Label Image

Image3.jpg (Image3)

A data table titled 'Recommended Concentrations and Doses of SENSORCAINE / SENSORCAINE WITH EPINEPHRINE in Adults,' detailing types of nerve blocks (such as local infiltration, peripheral nerve block, retrobulbar, sympathetic, caudal, lumbar epidural, epidural test dose, and dental). It lists SENSORCAINE concentrations, dose volumes in mL, corresponding mg doses, and associated motor block levels. Footnotes mention repeat doses with continuous techniques and epinephrine inclusion details for formulation variations.*

FDA Label Image

Image4.jpg (Image4)

A table listing examples of drugs associated with methemoglobinemia, organized by drug class. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with corresponding drug examples such as bupivacaine under Local anesthetics and phenobarbital under Anticonvulsants.*

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of bupivacaine hydrochloride, the active ingredient in Sensorcaine MPF 5 mg/mL injection solution. The diagram includes the molecular structure of bupivacaine, along with indications for hydrochloride (HCl) and water (H2O) components.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram of bupivacaine hydrochloride, the active ingredient in Sensorcaine MPF injection, solution 5 mg/mL by Henry Schein, Inc.*

FDA Label Image

Image5.jpg (Image5)

This data table lists product codes, units of sale, strengths, and NDC details for multiple presentations of a drug. It includes trays containing 25 single-dose vials in strengths ranging from 0.25% to 0.75%, with vial volumes of 10 mL and 30 mL. Each row provides specific NDC codes for both the trays and individual vials, along with corresponding dosage strengths in mg per mL.*

FDA Label Image

Image6.jpg (Image6)

A data table listing product codes, units of sale by NDC and packaging, and strengths for various formulations of bupivacaine hydrochloride injection. It details concentrations, total milligrams per vial, and vial sizes for trays of 25 single dose vials ranging from 0.25% to 0.75% strength.*

FDA Label Image

Image7.jpg (Image7)

A data table presenting product codes, units of sale, strengths, and packaging details for bupivacaine hydrochloride injection. It lists two strengths: 0.25% (2.5 mg/mL) and 0.5% (5 mg/mL), both available in trays of 25 vials. Each vial is a 50 mL multiple-dose vial, with corresponding NDC codes provided.*

FDA Label Image

Image8.jpg (Image8)

A data table showing product codes, units of sale, strengths, and packaging details for two formulations of bupivacaine hydrochloride injection solution. It lists a 0.25% strength (125 mg per 50 mL or 2.5 mg per mL) and a 0.5% strength (250 mg per 50 mL or 5 mg per mL), each available in trays of 25 with 50 mL multiple dose vials.*

FDA Label Image

Label1.jpg (Label1)

Label for Sensorcaine MPF 0.5% (bupivacaine hydrochloride) Injection, USP, a single dose vial containing 5 mg/mL strength in a 10 mL volume. The label includes usage instructions for nerve block, caudal, and epidural anesthesia, storage conditions, and packaging information by Henry Schein, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.